Carla Paola Costa

PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) AND THE PITUITARY: SAFETY AND EFFICACY

Abstract Peptide receptor radionuclide therapy (PRRT) is an emerging and promising targeted treatment for aggressive pituitary neuroendocrine tumours (PitNETs) and pituitary carcinomas refractory to conventional therapies. Its use is supported by the frequent expression of somato...